DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

Translate to Spanish or other 102 languages!

Dr. R. Alejandro Cruz, DHR Health Neurologist. Photo Courtesy DHR Health
- Advertisement -

Edinburg, Texas: DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

Under the expert guidance of neurologist Dr. R. Alejandro Cruz and the dedicated team at the DHR Health Neuroscience Institute, comprehensive protocols have been meticulously developed for administering Leqembi. These protocols encompass every aspect of patient care, from initial assessments to laboratory testing, radiology procedures, and establishing a state-of-the-art infusion center.

“I am very proud of the hard work of our team at DHR Health. Being the first facility to provide this groundbreaking therapy for Alzheimer’s disease marks a new era of hope for our community,” said Dr. R. Alejandro Cruz, DHR Health Neurologist.

- Advertisement -

As the largest physician-owned hospital in the United States and a leading healthcare provider in the Rio Grande Valley, DHR Health is immensely proud to be at the forefront of Alzheimer’s disease treatment in South Texas. “This achievement represents our ongoing commitment to bringing innovative and advanced treatment options to our community. We are proud to provide world-class care close to home,” said Marissa Castañeda, Senior Executive Vice President at DHR Health.

Dr. Cruz explains that Alzheimer’s disease is a progressive brain disorder characterized by changes in the brain that lead to the accumulation of certain proteins. These changes cause the brain to shrink and brain cells to die, resulting in dementia, which manifests as a gradual decline in memory, thinking, behavior, and social skills. The introduction of Leqembi offers hope for those affected by this debilitating condition, with the potential to improve quality of life and slow disease progression.

DHR Health continues delivering exceptional care, announcing a new chapter in Alzheimer’s treatment for the Rio Grande Valley. If you or a loved one are affected by Alzheimer’s, we encourage you to take the next step. To learn more about this groundbreaking treatment or to make an appointment, please contact the DHR Health Neuroscience Institute at (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS & Prominence Invite Seniors to Free Heart Health & Wellness Conference

Heart disease remains one of the most significant health challenges facing Americans, particularly older adults.

McAllen Cancer Survivor Heads to Washington to Urge Congress to Make Cancer a National Priority

McAllen resident and cancer survivor Elvia Gibbs will travel to Washington, D.C., to join hundreds of cancer patients, survivors and families from across the United States to urge Congress to make the fight against cancer a national priority.

Annual ‘Chalk the Walk’ Event Inspires Connection

Approximately 2.2 million Americans attempted suicide in 2024, according to the American Foundation for Suicide Prevention, while nearly 50,000 lives were lost to suicide. 

DHR Health’s Free Seminar on Breakthrough Treatment for Stroke Survivors, Sept. 19th

DHR Health’s Neuroscience Institute will host a free seminar for stroke survivors who want improved hand and arm movement as many stroke survivors experience impaired mobility and loss of function in the arm which can significantly affect their ability to   perform everyday activities.
- Advertisement -